Revelation Biosciences REVB
NASDAQ REVB
$0.77 -0.03 (-3.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Revelation Biosciences (REVB) Return on Assets [ROA] (2021 - 2026)

Updated

Revelation Biosciences (REVB) posted Return on Assets [ROA] of -81.83% for Q2 2026, up 91.29 percentage points from -173.12% a year earlier but down 6.21 percentage points from the prior quarter.

Analysis

Revelation Biosciences (REVB) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Revelation Biosciences' Return on Assets [ROA] came in at -99.65%, down 14.97 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -95.26 percentage points (FY2020 to FY2025).
  • In prior years, Revelation Biosciences' Return on Assets [ROA] was -84.69% in FY2024 (+13.04 pp), -97.73% in FY2023 (+190.24 pp), -287.97% in FY2022 (-282.38 pp) and -5.59% in FY2021 (-1.20 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -201.95% in Q3 2022 to a high of -15.64% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last three quarters, with an average year-over-year change of -8.71 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2023, with a gain of 152.05 percentage points; the weakest was Q4 2022, with a drop of 163.87 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -75.62% (Q1 2026), -74.23% (Q4 2025) and -90.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Revelation Biosciences 3.01 Mn -46.01 Mn - -81.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -81.83%
Mar 31, 2026 -75.62%
Dec 31, 2025 -74.23%
Sep 30, 2025 -90.44%
Jun 30, 2025 -173.12%
Mar 31, 2025 -154.22%
Dec 31, 2024 -119.37%
Sep 30, 2024 -89.92%
Jun 30, 2024 -70.66%
Mar 31, 2024 -66.43%
Dec 31, 2023 -65.50%
Sep 30, 2023 -49.90%
Jun 30, 2023 -34.96%
Mar 31, 2023 -49.94%
Dec 31, 2022 -179.51%
Sep 30, 2022 -201.95%
Jun 30, 2022 -171.76%
Mar 31, 2022 -197.39%
Dec 31, 2021 -15.64%
API Access

Revelation Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=REVB&period=max&api_key=YOUR_API_KEY